Recurrent Syncope following Substance Abuse; a Case Report
Archives of Academic Emergency Medicine,
Vol. 5 No. 1 (2017),
1 January 2017
,
Page e47
https://doi.org/10.22037/aaem.v5i1.172
Abstract
Drug abuse is considered as the most common poisoning in the world. Stimulants agent especially amphetamines and methamphetamines are among important abused substances. Different types of neurologic, psychiatric, respiratory, gastrointestinal, and cardiogenic complications have been reported to be related to methamphetamine consumption. Some of these substances could cause dysrhythmias which is the most prevalent etiology of cardiogenic syncope. Ecstasy, as one of the most commonly abused drugs, is known as a cause of cardiac dysrhythmias. Here we report a young boy who was admitted into the emergency department following three syncope attacks. All cardiac and neurologic assessments were normal; and finally ecstasy abuse was detected as the main etiology of syncopes.- Substance-related disorders
- syncope
- amphetamine
- N-Methyl-3
- 4-methylenedioxyamphetamine
- case report
How to Cite
References
Litovitz TL, Klein-Schwartz W, Rodgers GC, Cobaugh DJ, Youniss J, Omslaer JC, et al. 2001 Annual report of the American Association of Poison Control Centers toxic exposure surveillance system. The American journal of emergency medicine. 2002;20(5):391-452.
Mehrpour O. Methamphetamin abuse a new concern in Iran. DARU Journal of Pharmaceutical Sciences. 2012;20(1):1.
Albertson TE, Derlet RW, Van Hoozen BE. Methamphetamine and the expanding complications of amphetamines. Western Journal of Medicine. 1999;170(4):214.
Schifano F. A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities. Psychopharmacology. 2004;173(3-4):242-8.
Lewis DA, Dhala A. Syncope in the pediatric patient: the cardiologist's perspective. Pediatric clinics of North America. 1999;46(2):205-19.
Liechti ME, Kunz I, Kupferschmidt H. Acute medical problems due to Ecstasy use. Case-series of emergency department visits. Swiss medical weekly. 2005;135(43-44):652-7.
Al Shehri MA, Youssef AA. Acute myocardial infarction with multiple coronary thromboses in a young addict of amphetamines and benzodiazepines. Journal of the Saudi Heart Association. 2015.
Wijetunga M, Seto T, Lindsay J, Schatz I. Crystal methamphetamineâ€associated cardiomyopathy: tip of the iceberg? Journal of Toxicology: Clinical Toxicology. 2003;41(7):981-6.
Olfson M, Huang C, Gerhard T, Winterstein AG, Crystal S, Allison PD, et al. Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 2012;51(2):147-56.
Vearrier D, Greenberg MI, Miller SN, Okaneku JT, Haggerty DA. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine. Disease-a-Month. 2012;58(2):38-89.
Karlovšek MZ, Alibegović A, Balažic J. Our experiences with fatal ecstasy abuse (two case reports). Forensic science international. 2005;147:S77-S80.
Zhuo L, Liu Q, Liu L, Sun T-y, Wang R-s, Qu G-q, et al. Roles of 3, 4-methylenedioxymethamphetamine (MDMA)-induced alteration of connexin43 and intracellular Ca 2+ oscillation in its cardiotoxicity. Toxicology. 2013;310:61-72.
Won S, Hong RA, Shohet RV, Seto TB, Parikh NI. Methamphetamineâ€Associated Cardiomyopathy. Clinical cardiology. 2013;36(12):737-42.
- Abstract Viewed: 274 times
- PDF Downloaded: 152 times
- HTML Downloaded: 61 times
